Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (121-130 of 270) with videos related to

Pageof 27
Sort By:
Oncotarget|October 17, 2015
Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathwayKyung Seok Han, Na Li, Pater A Raven, et al.
The Journal of Urology|June 7, 2015
Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder CancerTetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo, et al.
Oncotarget|June 2, 2018
The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinibSebastian Frees, Betty Zhou, Kyung Seok Han, et al.
Urologic Oncology|November 30, 2020
A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinomaClaudia Kesch, Veronika Schmitt, Samir Bidnur, et al.
Oncogene|January 30, 2022
Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancerYang Yi, Yanqiang Li, Chao Li, et al.
EMBO Molecular Medicine|May 21, 2016
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosisNader Al Nakouzi, Chris Kedong Wang, Eliana Beraldi, et al.
The Journal of Biological Chemistry|December 7, 2007
The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cellsYingqiu Xie, Kexin Xu, Douglas E Linn, et al.
Oncogene|January 7, 2023
Chaperone-mediated autophagy promotes PCa survival during ARPI through selective proteome remodelingNicholas Nikesitch, Eliana Beraldi, Fan Zhang, et al.
The Prostate|March 10, 2009
A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancerJennifer A Locke, Ladan Fazli, Hans Adomat, et al.
The Prostate|September 26, 2006
Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgensVanessa C Thompson, Tanis G W Morris, Dawn R Cochrane, et al.
Pageof 27

Showing results (121-130 of 270) with videos related to

Sort By:
Pageof 27
Oncotarget|October 17, 2015
Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathwayKyung Seok Han, Na Li, Pater A Raven, et al.
The Journal of Urology|June 7, 2015
Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder CancerTetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo, et al.
Oncotarget|June 2, 2018
The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinibSebastian Frees, Betty Zhou, Kyung Seok Han, et al.
Urologic Oncology|November 30, 2020
A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinomaClaudia Kesch, Veronika Schmitt, Samir Bidnur, et al.
Oncogene|January 30, 2022
Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancerYang Yi, Yanqiang Li, Chao Li, et al.
EMBO Molecular Medicine|May 21, 2016
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosisNader Al Nakouzi, Chris Kedong Wang, Eliana Beraldi, et al.
The Journal of Biological Chemistry|December 7, 2007
The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cellsYingqiu Xie, Kexin Xu, Douglas E Linn, et al.
Oncogene|January 7, 2023
Chaperone-mediated autophagy promotes PCa survival during ARPI through selective proteome remodelingNicholas Nikesitch, Eliana Beraldi, Fan Zhang, et al.
The Prostate|March 10, 2009
A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancerJennifer A Locke, Ladan Fazli, Hans Adomat, et al.
The Prostate|September 26, 2006
Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgensVanessa C Thompson, Tanis G W Morris, Dawn R Cochrane, et al.
Pageof 27